| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Unknown |
| Molecule Category: | UNKNOWN |
| UNII: | UFH8805FKA |
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Depressive Disorder | 3 | D003866 | ClinicalTrials |
| Raynaud Disease | 3 | D011928 | ClinicalTrials |
| Kidney Neoplasms | 3 | D007680 | ClinicalTrials |
| Genital Neoplasms, Male | 3 | D005834 | ClinicalTrials |
| Breast Neoplasms | 3 | D001943 | ClinicalTrials |
| Pain | 3 | D010146 | ClinicalTrials |
| Head and Neck Neoplasms | 3 | D006258 | ClinicalTrials |
| Tobacco Use Disorder | 2 | D014029 | ClinicalTrials |
| Irritable Bowel Syndrome | 2 | D043183 | ClinicalTrials |
| Attention Deficit Disorder with Hyperactivity | 2 | D001289 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2108102 |
| FDA SRS | UFH8805FKA |
CONTENTS